findmyKOL
Clinical trialNCT07087002RecruitingPhase 1Interventional

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

SponsorStanford UniversityEnrollment18Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNSCNS NeuroblastomaCentral Nervous System Embryonal TumorEmbryonal Tumor With Multilayered Rosettes (ETMR)FOXR2-activatedMedulloblastoma+4 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Lucile Packard Children'S Hospital Stanford

    Palo Alto, California, United States

    Katherine Ryan, DOSabine Heitzeneder, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Aug 2025
Primary completion
31 Aug 2027
Completion
31 Aug 2027
Last update posted
27 Jan 2026
Registered enrollment
18
Registry id
NCT07087002
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.